The expression of miR-940 is under negative control of RIP1, a TNFα receptor binding protein, and the authors speculate that interference with the RIP1/miR-940/DUSP1/JNK pathway could sensitize lung cancer cells to cisplatin. This evidence concerns the gene MAPK8 and lung carcinoma.